NRG1 and ischemic stroke: Therefore, we engineered AdMSCs to boost NRG1 secretion by adenoviral infection and investigated whether these NRG1-modified AdMSCs (NRG1-AdMSCs) could have better therapeutic potentials after ischemic stroke in rats.